FI971127A0 - 2,4-diaminopyrimidiini-3-oksidin tai jonkin sen suolan käyttö kollageenin kypsymis- ja rakentumishäiriöiden hoitamiseen - Google Patents

2,4-diaminopyrimidiini-3-oksidin tai jonkin sen suolan käyttö kollageenin kypsymis- ja rakentumishäiriöiden hoitamiseen

Info

Publication number
FI971127A0
FI971127A0 FI971127A FI971127A FI971127A0 FI 971127 A0 FI971127 A0 FI 971127A0 FI 971127 A FI971127 A FI 971127A FI 971127 A FI971127 A FI 971127A FI 971127 A0 FI971127 A0 FI 971127A0
Authority
FI
Finland
Prior art keywords
pct
disorders
oxide
diaminopyrimidine
salts
Prior art date
Application number
FI971127A
Other languages
English (en)
Swedish (sv)
Other versions
FI971127A (fi
Inventor
Yann Mahe
Lionel Breton
Jean-Baptiste Galey
Bruno Bernard
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of FI971127A0 publication Critical patent/FI971127A0/fi
Publication of FI971127A publication Critical patent/FI971127A/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI971127A 1994-09-19 1997-03-18 2,4-diaminopyrimidiini-3-oksidin tai jonkin sen suolan käyttö kollageenin kypsymis- ja rakentumishäiriöiden hoitamiseen FI971127A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9411133A FR2724561B1 (fr) 1994-09-19 1994-09-19 Utilisation du 2,4-diamino pyrimidine 3-oxyde ou de l'un de ses sels dans le traitement des desordres de la maturation et de la structuration du collagene
PCT/FR1995/001197 WO1996009048A1 (fr) 1994-09-19 1995-09-19 Utilisation du 2,4-diamino pyrimidine 3-oxyde ou de l'un de ses sels dans le traitement des desordres de la maturation et de la structuration du collagene

Publications (2)

Publication Number Publication Date
FI971127A0 true FI971127A0 (fi) 1997-03-18
FI971127A FI971127A (fi) 1997-03-18

Family

ID=9467049

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971127A FI971127A (fi) 1994-09-19 1997-03-18 2,4-diaminopyrimidiini-3-oksidin tai jonkin sen suolan käyttö kollageenin kypsymis- ja rakentumishäiriöiden hoitamiseen

Country Status (22)

Country Link
US (1) US5846552A (fi)
EP (1) EP0783307B1 (fi)
JP (1) JP2945482B2 (fi)
KR (1) KR100250939B1 (fi)
CN (1) CN1070702C (fi)
AT (1) ATE213414T1 (fi)
AU (1) AU691336B2 (fi)
BR (1) BR9508841A (fi)
CA (1) CA2199995C (fi)
CZ (1) CZ284476B6 (fi)
DE (1) DE69525539T2 (fi)
DK (1) DK0783307T3 (fi)
ES (1) ES2171550T3 (fi)
FI (1) FI971127A (fi)
FR (1) FR2724561B1 (fi)
HU (1) HU223143B1 (fi)
MX (1) MX9701996A (fi)
NO (1) NO311784B1 (fi)
PL (1) PL186385B1 (fi)
PT (1) PT783307E (fi)
RU (1) RU2153874C2 (fi)
WO (1) WO1996009048A1 (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0875781B1 (en) * 1997-04-30 2005-08-17 JSR Corporation Liquid crystal alignment layer, production method for the same, and liquid crystal display device comprising the same
US7763587B2 (en) 2002-06-13 2010-07-27 L'oreal S.A. Derivative of glucose and of vitamin F, compositions comprising it, uses and preparation process
US7326717B2 (en) * 2003-05-06 2008-02-05 L'oreal Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof
FR2871688B1 (fr) 2004-06-16 2008-05-16 Oreal Procede pour favoriser la penetration d'un actif et composition permettant sa mise en oeuvre
US7300649B2 (en) 2005-02-11 2007-11-27 Genepharm, Inc. Cosmetic and cosmeceutical compositions for restoration of skin barrier function
FR2902324B1 (fr) * 2006-06-20 2009-04-03 Oreal Utilisation d'acide ellagique pour le traitement de la canitie
EP1897533A1 (en) * 2006-09-08 2008-03-12 Revotar Biopharmaceuticals AG Use of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-alpha -D-mannopyranosyl-oxy)-phenyl] hexane for the preparation of cosmetic compositions
EP1946756A1 (en) * 2007-01-17 2008-07-23 Revotar Biopharmaceuticals AG Use of entacapone in cosmetic, dermatological and pharmaceutical compositions
EP2149368B1 (en) 2008-07-29 2018-05-30 L'Oréal Cosmetic and dermatological use of probiotic Lactobacillus paracasei microorganisms for the treatment of greasy scalp disorders
FR2951938B1 (fr) 2009-10-30 2012-01-06 Oreal Utilisation d'un extrait de punica granatum pour lutter contre la canitie
CN104398418A (zh) * 2014-11-06 2015-03-11 陈爱华 一种防脱发护发素
FR3130153A1 (fr) 2021-12-15 2023-06-16 L'oreal Utilisation d’au moins un dérivé de pyrimidine 3-oxyde pour renforcer la fonction barrière de la peau

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0049902A3 (en) * 1980-10-15 1982-09-01 Teijin Limited Novel thiazolo(3,2-a)pyrimidines, derivatives thereof, processes for production thereof, and pharmaceutical use thereof
FR2644460A1 (fr) * 1989-03-16 1990-09-21 Oreal Esters retinoiques de d-desosamine, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
LU87766A1 (fr) * 1990-07-20 1992-03-11 Oreal Utilisation de derives de pyrimidine 3-oxyde pour freiner la chute des cheveux et compositions topiques mises en oeuvre
EP0548883A1 (de) * 1991-12-24 1993-06-30 Hoechst Aktiengesellschaft Substituierte Pyridin-N-oxide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
DE69525539T2 (de) 2002-09-26
CA2199995C (fr) 2002-01-15
DE69525539D1 (de) 2002-03-28
DK0783307T3 (da) 2002-06-03
HU223143B1 (hu) 2004-03-29
MX9701996A (es) 1997-06-28
FI971127A (fi) 1997-03-18
CZ84297A3 (en) 1997-08-13
HUT76796A (en) 1997-11-28
JPH10506886A (ja) 1998-07-07
RU2153874C2 (ru) 2000-08-10
FR2724561A1 (fr) 1996-03-22
BR9508841A (pt) 1999-05-04
CZ284476B6 (cs) 1998-12-16
PT783307E (pt) 2002-07-31
JP2945482B2 (ja) 1999-09-06
ATE213414T1 (de) 2002-03-15
ES2171550T3 (es) 2002-09-16
CN1070702C (zh) 2001-09-12
EP0783307A1 (fr) 1997-07-16
AU691336B2 (en) 1998-05-14
PL186385B1 (pl) 2004-01-30
NO971182D0 (no) 1997-03-14
FR2724561B1 (fr) 1996-12-13
PL319279A1 (en) 1997-08-04
WO1996009048A1 (fr) 1996-03-28
US5846552A (en) 1998-12-08
CN1159755A (zh) 1997-09-17
AU3476595A (en) 1996-04-09
EP0783307B1 (fr) 2002-02-20
CA2199995A1 (fr) 1996-03-28
KR970705998A (ko) 1997-11-03
NO311784B1 (no) 2002-01-28
KR100250939B1 (ko) 2000-05-01
NO971182L (no) 1997-05-14

Similar Documents

Publication Publication Date Title
ATE144420T1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
ES2248356T3 (es) Compuestos para tratar la enfermedad de alzheimer.
DE69523169D1 (de) Verwendung von Mangiferin oder seinen Derivaten zur kosmetischen Anwendung
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
FI971127A0 (fi) 2,4-diaminopyrimidiini-3-oksidin tai jonkin sen suolan käyttö kollageenin kypsymis- ja rakentumishäiriöiden hoitamiseen
BR9509975A (pt) Formulação farmacêutica
DK0901790T3 (da) Anvendelse af moxonidin til behandling af neuropatisk smerte
DE69805305T2 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
HUP9902415A2 (hu) Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására
ATE200624T1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
ES2190499T3 (es) Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer.
SE9500897D0 (sv) The pharmacological use of certain cystine derivatives
ES2181160T3 (es) Derivados de 1,4-dihidropiridina y su utilizacion en terapia.
ATE167055T1 (de) 4-guanidinobutyramid zur verbesserung des blutkreislaufs
UA26407C2 (uk) Спосіб очищеhhя уражеhих шкірhих покривів людиhи при захворюваhhі псоріазом